A Rare Case of Cerebral Amyloidoma Mimicking Thalamic Glioma in a Rheumatoid Arthritis Patient
Abstract
1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
Abbreviations | Full forms |
RA | Rheumatoid arthritis |
CA | Cerebral amyloidosis |
SAA | Serum amyloid alpha |
CSF | Cerebrospinal fluid |
H&E | Hematoxylin and eosin |
LPSs | Lipopolysaccharides |
IL | Interleukin |
TNF | Tumor necrosis factor |
CAA | Cerebral amyloid angiopathy |
DMRADs | Disease-modifying anti-rheumatic drugs |
References
- Pozzan, M.; Indennidate, C.; Varrà, G.G.; Sinagra, G.; Merlo, M.; Pagura, L. Amyloidosis and Amyloidogenesis. Heart Fail. Clin. 2024, 20, 249–260. [Google Scholar] [CrossRef] [PubMed]
- Bustamante, J.G.; Zaidi, S.R.H. Amyloidosis. 2023. Available online: https://www.ncbi.nlm.nih.gov/books/NBK470285/ (accessed on 13 March 2025).
- Papa, R.; Lachmann, H.J. Secondary, AA, Amyloidosis. Rheum. Dis. Clin. N. Am. 2018, 44, 585–603. [Google Scholar] [CrossRef] [PubMed]
- Kapoor, A.; Gowda, A.M.; Kaur, S.; Estifan, E.; Maroules, M. A Rare Case of Cerebral Amyloidoma Mimicking a Hemorrhagic Malignant Central Nervous System Neoplasm. Cureus 2020, 12, e7245. [Google Scholar] [CrossRef]
- Sousa, L.; Coelho, T.; Taipa, R. CNS Involvement in Hereditary Transthyretin Amyloidosis. Neurology 2021, 97, 1111–1119. [Google Scholar] [CrossRef]
- Szidonya, L.; Nickerson, J.P. Cerebral Amyloid Angiopathy. Radiol. Clin. N. Am. 2023, 61, 551–562. [Google Scholar] [CrossRef]
- Landau, D.; Avgeropoulos, N.; Ma, J. Cerebral amyloidoma mimicking intracranial tumor: A case report. J. Med. Case Rep. 2010, 4, 308. [Google Scholar] [CrossRef] [PubMed]
- Ragel, B.T.; Blumenthal, D.T.; Browd, S.R.; Salzman, K.L.; Jensen, R.L. Intracerebral Amyloidoma Can Mimic High-Grade Glioma on Magnetic Resonance Imaging and Spectroscopy. Arch. Neurol. 2006, 63, 906–907. [Google Scholar] [CrossRef]
- Ogilvie, J.; Zhao, R.; Camelo-Piragua, S.; Ibrahim, M.; Lobo, R.; Kim, J. Magnetic resonance imaging of a temporal lobe cerebral amyloidoma. Radiol. Case Rep. 2022, 17, 2820–2823. [Google Scholar] [CrossRef]
- Wisniowski, B.; Wechalekar, A. Confirming the Diagnosis of Amyloidosis. Acta Haematol. 2020, 143, 312–321. [Google Scholar] [CrossRef]
- Real de Asua, D.; Galvan, J.M.; Filigghedu, M.T.; Trujillo, D.; Costa, R.; Cadinanos, J. Systemic AA amyloidosis: Epidemiology, diagnosis, and management. Clin. Epidemiol. 2014, 6, 369–377. [Google Scholar] [CrossRef]
- Dhillon, V.; Woo, P.; Isenberg, D. Amyloidosis in the rheumatic diseases. Ann. Rheum. Dis. 1989, 48, 696–701. [Google Scholar] [CrossRef]
- Ishihara, T.; Nagasawa, T.; Yokota, T.; Gondo, T.; Takahashi, M.; Uchino, F. Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis. Hum. Pathol. 1989, 20, 891–895. [Google Scholar] [CrossRef]
- Schröder, R.; Linke, R.P. Cerebrovascular involvement in systemic AA and AL amyloidosis: A clear haematogenic pattern. Virchows Arch. 1999, 434, 551–560. [Google Scholar] [CrossRef]
- Brunger, A.F.; Nienhuis, H.L.A.; Bijzet, J.; Hazenberg, B.P.C. Causes of AA amyloidosis: A systematic review. Amyloid 2019, 27, 1–12. [Google Scholar] [CrossRef]
- De Buck, M.; Gouwy, M.; Wang, J.M.; Van Snick, J.; Proost, P.; Struyf, S.; Van Damme, J. The cytokine-serum amyloid A-chemokine network. Cytokine Growth Factor. Rev. 2016, 30, 55–69. [Google Scholar] [CrossRef]
- Obici, L.; Merlini, G. AA amyloidosis: Basic knowledge, unmet needs and future treatments. Swiss Med. Wkly. 2012, 142, 2122. [Google Scholar] [CrossRef]
- Kuroda, T.; Tanabe, N.; Sato, H.; Nakatsue, T.; Wada, Y.; Murakami, S.; Nakano, M.; Narita, I. Distribution of Amyloid Deposits in the Kidneys of a Patient with Reactive Amyloidosis Associated with Rheumatoid Arthritis. BMC Res. Notes 2013, 6, 231. [Google Scholar] [CrossRef]
- Buck, M.; Gouwy, M.; Wang, J.; Snick, J.; Opdenakker, G.; Struyf, S.; Damme, J. Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults. Curr. Med. Chem. 2016, 23, 1725–1755. [Google Scholar] [CrossRef]
- Cunnane, G.; Grehan, S.; Geoghegan, S.; McCormack, C.; Shields, D.; Whitehead, A.S.; Bresnihan, B.; Fitzgerald, O. Serum amyloid A in the assessment of early inflammatory arthritis. J. Rheumatol. 2000, 27, 58–63. [Google Scholar]
- O’Hara, R.; Murphy, E.P.; Whitehead, A.S.; FitzGerald, O.; Bresnihan, B. Acute-phase Serum Amyloid a Production by Rheumatoid Arthritis Synovial Tissue. Arthritis Res. 2000, 2, 142–144. [Google Scholar] [CrossRef]
- Connolly, M.; Marrelli, A.; Blades, M.; McCormick, J.; Maderna, P.; Godson, C.; Mullan, R.; FitzGerald, O.; Bresnihan, B.; Pitzalis, C.; et al. Acute Serum Amyloid A Induces Migration, Angiogenesis, and Inflammation in Synovial Cells In Vitro and in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model. J. Immunol. 2010, 184, 6427–6437. [Google Scholar] [CrossRef]
- Basile, M.S.; Ciurleo, R.; Bramanti, A.; Petralia, M.C.; Fagone, P.; Nicoletti, F.; Cavalli, E. Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms. Int. J. Mol. Sci. 2021, 22, 1185. [Google Scholar] [CrossRef]
- Gallucci, M.; Caulo, M.; Splendiani, A.; Russo, R.; Ricci, A.; Galzio, R. Neuroradiological findings in two cases of isolated amyloidoma of the central nervous system. Neuroradiology 2002, 44, 333–337. [Google Scholar] [CrossRef]
- Nossek, E.; Bashat, D.B.; Artzi, M.; Rosenberg, K.; Lichter, I.; Shtern, O.; Ami, H.B.; Aizenstein, O.; Vlodavsky, E.; Constantinescu, M.; et al. The role of advanced MR methods in the diagnosis of cerebral amyloidoma. Amyloid 2009, 16, 94–98. [Google Scholar] [CrossRef]
- Fischer, B.; Palkovic, S.; Rickert, C.; Weckesser, M.; Wassmann, H. Cerebral AL lambda-amyloidoma: Clinical and pathomorphological characteristics. Review of the literature and of a patient. Amyloid 2007, 14, 11–19. [Google Scholar] [CrossRef]
- Dasari, S.; Theis, J.D.; Vrana, J.A.; Rech, K.L.; Dao, L.N.; Howard, M.T.; Dispenzieri, A.; Gertz, M.A.; Hasadsri, L.; Highsmith, W.E.; et al. Amyloid Typing by Mass Spectrometry in Clinical Practice: A Comprehensive Review of 16,175 Samples. Mayo Clin. Proc. 2020, 95, 1852–1864. [Google Scholar] [CrossRef]
- Catafau, A.M.; Bullich, S. Amyloid PET imaging: Applications beyond Alzheimer’s disease. Clin. Transl. Imaging 2015, 3, 39–55. [Google Scholar] [CrossRef]
- Foreid, H.; Barroso, C.; Evangelista, T.; Campos, A.; Pimentel, J. Intracerebral amyloidoma: Case report and review of the literature. Clin. Neuropathol. 2010, 29, 217–222. [Google Scholar] [CrossRef]
- Nakamura, T. Amyloid A amyloidosis secondary to rheumatoid arthritis: Pathophysiology and treatments. Clin. Exp. Rheumatol. 2011, 29, 850–857. [Google Scholar]
- Okuda, Y.; Ohnishi, M.; Matoba, K.; Jouyama, K.; Yamada, A.; Sawada, N.; Mokuda, S.; Murata, Y.; Takasugi, K. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. Mod. Rheumatol. 2014, 24, 137–143. [Google Scholar] [CrossRef]
- Matsuda, M.; Morita, H.; Ikeda, S. Long-term Follow-up of Systemic Reactive AA Amyloidosis Secondary to Rheumatoid Arthritis: Successful Treatment with Intermediate-dose Corticosteroid. Intern. Med. 2002, 41, 403–407. [Google Scholar] [CrossRef] [PubMed]
- Rincón-Arias, N.; Romo, J.A.; Galvis, K.A.; Sierra, M.A.; Pulido, P.A.; Espinosa, S.; Castro, E.; Zorro-Guio, O.F.; Ordoñez-Rubiano, E.G. Long-Term Progression of a Residual Cerebral Amyloidoma: An Illustrative Case and Systematic Review. World Neurosurg. 2024, 190, e1100–e1115. [Google Scholar] [CrossRef] [PubMed]
- Meier, T.; Hazenfield, J.M.; Girnius, S.; Hagen, M.; Warnick, R.E.; Kharofa, J. A rare case of central nervous system amyloidoma treated with fractionated radiotherapy. J. Neurosurg. 2017, 127, 338–341. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Saleh, E.; Abdelaziz, N.; Ramahi, M.; Loukousia, A.; Birbilis, T.; Kanakis, D. A Rare Case of Cerebral Amyloidoma Mimicking Thalamic Glioma in a Rheumatoid Arthritis Patient. Pathophysiology 2025, 32, 31. https://doi.org/10.3390/pathophysiology32030031
Saleh E, Abdelaziz N, Ramahi M, Loukousia A, Birbilis T, Kanakis D. A Rare Case of Cerebral Amyloidoma Mimicking Thalamic Glioma in a Rheumatoid Arthritis Patient. Pathophysiology. 2025; 32(3):31. https://doi.org/10.3390/pathophysiology32030031
Chicago/Turabian StyleSaleh, Elyaa, Nour Abdelaziz, Malaak Ramahi, Antonia Loukousia, Theodossios Birbilis, and Dimitrios Kanakis. 2025. "A Rare Case of Cerebral Amyloidoma Mimicking Thalamic Glioma in a Rheumatoid Arthritis Patient" Pathophysiology 32, no. 3: 31. https://doi.org/10.3390/pathophysiology32030031
APA StyleSaleh, E., Abdelaziz, N., Ramahi, M., Loukousia, A., Birbilis, T., & Kanakis, D. (2025). A Rare Case of Cerebral Amyloidoma Mimicking Thalamic Glioma in a Rheumatoid Arthritis Patient. Pathophysiology, 32(3), 31. https://doi.org/10.3390/pathophysiology32030031